Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 7:32 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2089–2112 of 18,278 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Controlled Group Clear all

Conditions: Maternal Behavior, Maternal Addiction
Interventions: Oxytocin, Placebos, Functional MRI scanning; Drug · Procedure
Lead sponsor: Lane Strathearn, MBBS PhD; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 2
States / cities: New Haven, Connecticut • Iowa City, Iowa

Conditions: Food Allergy
Interventions: Simulation of epinephrine self-injection; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 13 Years to 17 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity, Smoking Cessation, Bariatric Surgery Patients
Interventions: Naltrexone hydrochloride, Bupropion Hydrochloride Extended-release, Cognitive-Behavioral Therapy; Drug · Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 65 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Type2Diabetes, Pregnancy in Diabetic
Interventions: Dexcom G6 CGM, Participant Finger Stick Glucose Monitoring; Device · Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Alzheimer Disease
Interventions: Arm 1 Education Session; Other
Lead sponsor: Daniela Moga; Other
Eligibility: 65 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Hypertension
Interventions: Hula and heart health education; Behavioral
Lead sponsor: University of Hawaii; Other
Eligibility: 18 Years and older
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Diabetes
Interventions: Saxagliptin, Dapagliflozin, Glimepiride, Placebo; Drug · Other
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 120 Years
Enrollment: 444 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 22
States / cities: Birmingham, Alabama • Chandler, Arizona • Tempe, Arizona + 17 more

Conditions: Wounds and Injuries
Interventions: Samples will be collected; Procedure
Lead sponsor: Gayle Gordillo; Other
Eligibility: 18 Years to 69 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2018
U.S. locations: 2
States / cities: Columbus, Ohio

Conditions: Health Behavior, Chronic Disease
Interventions: Workplace Solutions Consulting approach, Delayed intervention; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: Not listed
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Chronic Low Back Pain
Interventions: Rage Against the Pain (RAP), Control; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Hines, Illinois

Conditions: Mental Health Wellness 1
Interventions: Sudarshan Kriya Yoga, Mindfulness-Based Stress Reduction, Emotional Intelligence; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Healthy Aging
Interventions: Continuous theta burst transcranial magnetic stimulation; Device
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 80 Years
Enrollment: 248 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Neural Connectivity
Interventions: Blood Oxygen Level Dependent (BOLD) functional magnetic imaging (fMRI); Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 55 Years to 75 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Proliferative Diabetic Retinopathy
Interventions: Macugen ® (pegaptanib sodium); Drug
Lead sponsor: Valley Retina Institute; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2014
U.S. locations: 1
States / cities: McAllen, Texas

Conditions: Postdural Puncture Headache
Interventions: 0.5% bupivacaine, normal saline; Drug
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Amputation
Interventions: Needs-based intervention (physical, psychological, or both); Other
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years to 89 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 3
States / cities: Chicago, Illinois • Bethesda, Maryland • Minneapolis, Minnesota

Conditions: Schizophrenia
Interventions: AZD2624, Olanzapine, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Rockville, Maryland

Conditions: Epilepsy, Depressive Symptoms, Depression, Seizure Disorder
Interventions: Project UPLIFT; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 21 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 4
States / cities: Atlanta, Georgia • Ann Arbor, Michigan • Houston, Texas + 1 more

Conditions: Multiple Sclerosis
Interventions: ACT-128800 Dose 1, Placebo, ACT-128800 Dose 2, ACT-128800 Dose 3; Drug
Lead sponsor: Actelion; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 464 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 25
States / cities: Scottsdale, Arizona • Tucson, Arizona • Sacramento, California + 22 more

Conditions: Septic Shock, Vasodilatory Shock
Interventions: Angiotensin II; Drug
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip, Overweight, Obesity, Physical Inactivity, Weight Loss
Interventions: OA CARE Intervention, Usual Care control group; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 99 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Stress, Self-Efficacy, Heart Disease Risk Factors, Depression Symptoms, Awareness, Perceived Stress, Lifestyle Intervention, Behavior Change
Interventions: Experimental: Black Women's Stress and Wellness (B-SWELL) arm, Active Comparator: Wellness (WE) arm; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 45 Years to 64 Years · Female only
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Cerebral Hypoperfusion
Interventions: Electronic CPP pager alert; Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Depression
Interventions: Venlafaxine XR, Placebo, JNJ26489112; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 14
States / cities: Arcadia, California • Escondido, California • San Diego, California + 11 more

Search by objective public record fields.

Oxytocin and Brain Responses in Maternal Addiction

Self-injection and Self-management

A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients

AT GOAL: Adopting Technology for Glucose Optimization and Lifestyle in Pregnancy

A Pilot Study to Reduce Inappropriate Anticholinergic Prescribing in the Elderly

Ola Hou i ka Hula: Hula and Hypertension

A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone

Mechanisms Regulating Wound Vascularization

Marketing Workplace Chronic Disease Prevention

Rage Against the Pain to Address Chronic Low Back Pain Among Veterans

Yale Wellness Project

Evaluating the Neurocomputational Mechanisms of Explore-Exploit Decision Making in Older Adults

Neural Activation and Connectivity in Response to Exercise and Cognitive Training

Macugen for Proliferative Diabetic Retinopathy Study With Extended Dosing (M-PDRS ED)

Study Evaluating Sphenopalatine Ganglion Block (SPGB) for Treatment of Postdural Puncture Headache (PDPH)

Personalized Mobility Interventions Using Smart Sensor Resources for Lower-Limb Prosthesis Users

Phase IIA Study in Patients With Schizophrenia

Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT

Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis

Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock

OA Clinic-Community CARE Model

Using Life's Essential 8 in Midlife Black Women

Real-Time Decision Support for Improving Intraoperative Cerebral Perfusion Pressure

A Safety and Efficacy Study of JNJ26489112 in Patients With Treatment-Resistant Major Depressive Disorder